Repositorio Dspace

Listar01. Consejería de Salud por tema "Early Detection of Cancer"

Listar01. Consejería de Salud por tema "Early Detection of Cancer"

Ordenar por:Orden:Resultados:

  • Fortner, Renee-T; Vitonis, Allison-F; Schock, Helena; Huesing, Anika; Johnson, Theron; Fichorova, Raina-N; Fashemi, Titilayo; Yamamoto, Hidemi-S; Tjonneland, Anne; Hansen, Louise; Overvad, Kim; Boutron-Ruault, Marie-Christine; Kvaskoff, Marina; Severi, Gianluca; Boeing, Heiner; Trichopoulou, Antonia; Benetou, Vassiliki; La-Vecchia, Carlo; Palli, Domenico; Sieri, Sabina; Tumino, Rosario; Matullo, Giuseppe; Mattiello, Amalia; Onland-Moret, N-Charlotte; Peeters, Petra-H; Weiderpass, Elisabete; Gram, Inger-Torhild; Jareid, Mie; Quirós, José-Ramón; Duell, Eric-J; Sánchez, María-José; Chirlaque-López, María-Dolores; Ardanaz, Eva; Larrañaga, Nerea; Nodin, Bjorn; Brandstedt, Jenny; Idahl, Annika; Khaw, Kay-Tee; Allen, Naomi; Gunter, Marc; Johansson, Mattias; Dossus, Laure; Merritt, Melissa-A; Riboli, Elio; Cramer, Daniel-W; Kaaks, Rudolf; Terry, Kathryn-L (BMC, 2017-03-20)
    BACKGROUND: Ovarian cancer early detection markers CA125, CA15.3, HE4, and CA72.4 vary between healthy women, limiting their utility for screening. METHODS: We evaluated cross-sectional relationships between lifestyle and ...
  • Sasamoto, Naoko; Babic, Ana; Rosner, Bernard-A; Fortner, Renee-T; Vitonis, Allison-F; Yamamoto, Hidemi; Fichorova, Raina-N; Titus, Linda-J; Tjonneland, Anne; Hansen, Louise; Kvaskoff, Marina; Fournier, Agnes; Mancini, Francesca-Romana; Boeing, Heiner; Trichopoulou, Antonia; Peppa, Eleni; Karakatsani, Anna; Palli, Domenico; Grioni, Sara; Mattiello, Amalia; Tumino, Rosario; Fiano, Valentina; Onland-Moret, N-Charlotte; Weiderpass, Elisabete; Gram, Inger-T; Quirós, J-Ramón; Lujan-Barroso, Leila; Sánchez, Maria-Jose; Colorado-Yohar, Sandra; Barricarte-Gurrea, Aurelio; Amiano, Pilar; Idahl, Annika; Lundin, Eva; Sartor, Hanna; Khaw, Kay-Tee; Key, Timothy-J; Muller, David; Riboli, Elio; Gunter, Marc; Dossus, Laure; Trabert, Britton; Wentzensen, Nicolás; Kaaks, Rudolf; Cramer, Daniel-W; Tworoger, Shelley-S; Terry, Kathryn-L (BMC, 2019-11-26)
    BACKGROUND: Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. ...
  • Mukama, Trasias; Fortner, Renee-T; Katzke, Verena-A; Hynes, Lucas-Cory; Petrera, Agnese; Hauck, Stefanie-M; Johnson, Theron; Schulze, Matthias-B; Schiborn, Catarina; Rostgaard-Hansen, Agnetha-Linn; Tjonneland, Anne; Overvad, Kim; Sánchez-Pérez, María-José; Crous-Bou, Marta; Chirlaque-López, María-Dolores; Amiano, Pilar; Ardanaz, Eva; Watts, Eleanor-L; Travis, Ruth-C; Sacerdote, Carlotta; Grioni, Sara; Masala, Giovanna; Signoriello, Simona; Tumino, Rosario; Gram, Inger-Torhild; Sandanger, Torkjel-Manning; Sartor, Hanna; Lundin, Eva; Idahl, Annika; Heath, Alicia-K; Dossus, Laure; Weiderpass, Elisabete; Kaaks, Rudolf (SPRINGERNATURE, 2022-05)
    BACKGROUND: CA125 is the best available yet insufficiently sensitive biomarker for early detection of ovarian cancer. There is a need to identify novel biomarkers, which individually or in combination with CA125 can achieve ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta